Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calasept versus chair-side mixed calcium hydroxide for periapical granuloma
PACTR202504838489580Completed
- Sponsor
- Ololade Akinyemi
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of calcium hydroxide in Periapical granuloma and apical periodontitis (AP) (2 arms), sponsored by Ololade Akinyemi. Primary endpoint: Lesion size reduction. Started Aug 2018; status: completed.
02
Drugs
calcium hydroxide
03
Conditions
Periapical granulomaapical periodontitis (AP)
Beyond the preview
Go deeper on PACTR202504838489580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202504838489580.